| P50 | author | Benjamin Lebwohl | Q91475188 |
| | Norelle R Reilly | Q114575657 |
| | Jonas F. Ludvigsson | Q42613009 |
| P2093 | author name string | Rolf Hultcrantz | |
| | Peter H R Green | |
| P2860 | cites work | The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research | Q24644519 |
| | Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis | Q28247105 |
| | Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD) | Q83683089 |
| | Non-alcoholic steatohepatitis occurs in celiac disease and is associated with cellular stress | Q85893778 |
| | The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease | Q86080277 |
| | Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease | Q28275665 |
| | The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis | Q28345942 |
| | Steatohepatitis: a tale of two "hits"? | Q29547771 |
| | Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | Q29614911 |
| | Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers | Q33417880 |
| | Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa | Q33485528 |
| | Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis | Q33563333 |
| | External review and validation of the Swedish national inpatient register | Q33928068 |
| | Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. | Q33987343 |
| | Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease | Q34595882 |
| | World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis | Q34662402 |
| | Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease | Q34758939 |
| | Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease | Q36131251 |
| | Coeliac disease and risk of tuberculosis: a population based cohort study. | Q36203298 |
| | Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis | Q36532010 |
| | Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome | Q37126971 |
| | Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets. | Q37162447 |
| | Causes of death in patients with celiac disease in a population-based Swedish cohort | Q38483066 |
| | Coeliac disease and body mass index: a study of two Swedish general population-based registers | Q39956051 |
| | Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing | Q41454044 |
| | Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease | Q41965718 |
| | Socioeconomic position and education in patients with coeliac disease | Q43652502 |
| | Celiac disease in normal-weight and overweight children: clinical features and growth outcomes following a gluten-free diet | Q45257702 |
| | A pathogenetic link between non-alcoholic fatty liver disease and celiac disease. | Q45325981 |
| | Small-intestinal histopathology and mortality risk in celiac disease | Q45749240 |
| | The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years | Q45787554 |
| | Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. | Q46085888 |
| | Searching for coeliac disease in patients with non-alcoholic fatty liver disease | Q47361870 |
| | Body mass index in celiac disease: beneficial effect of a gluten-free diet. | Q50582298 |
| | Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. | Q50784627 |
| | The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran. | Q51431876 |
| | Risk of tuberculosis in a large sample of patients with coeliac disease - a nationwide cohort study | Q57209228 |
| | Celiac Disease and Risk of Liver Disease: A General Population-Based Study | Q57697794 |
| | Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity | Q62066885 |
| | Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis | Q69104939 |
| | Luminal bacteria and small-intestinal permeability | Q73452737 |
| | The liver in celiac disease | Q81517623 |
| P433 | issue | 6 | |
| P921 | main subject | liver disease | Q929737 |
| | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| | non-alcoholic fatty liver | Q66299798 |
| P304 | page(s) | 1405-1411 | |
| P577 | publication date | 2015-01-21 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease | |
| P478 | volume | 62 | |